Â鶹ÊÓƵ

Paul, Weiss advised leading physician-owned community oncology practice Florida Cancer Specialists & Research Institute, LLC (FCS) in the approximately $2.5 billion all-cash sale of a 70% stake in its internal business and administrative services arm, Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), to McKesson Corporation. Under the terms of the deal, FCS physicians retained a minority interest in Core Ventures, which joined McKesson’s The US Oncology, a leading oncology organization dedicated to advancing local and affordable cancer care and better patient outcomes.

The Paul, Weiss team was led by corporate partners Krishna Veeraraghavan and Cullen Sinclair, and included partners Thomas de la Bastide and Luke Jennings, and counsel Mary-Ann Awada and Arik Hirschfeld; antitrust partners Christopher Wilson, Scott Sher and Katharine Haigh, and counsel John Magruder; tax partner Lindsay Parks; executive compensation partner Jarrett Hoffman and counsel ; litigation partner Andrew Gordon and counsel Audrey Paquet; intellectual property partner Chuck Googe; real estate partner Peter Fisch; and environmental counsel William O’Brien.